TOKYO--(BUSINESS WIRE)--Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer ...
The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...
Aug. 19, 2004 — The holmium laser core-through urethrotomy (HolCTU) is a safe and simple treatment for traumatic obliterative urethral strictures, according to the results of an interventional case ...
TOKYO--(BUSINESS WIRE)--A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six ...
Urethral strictures refer to the narrowing of the urethra, which is the tube that carries urine out of the body. This condition is typically caused by scarring, which can block or narrow the urethra, ...
Guidelines for male urethral stricture The guidelines provide a clinical framework for the diagnosis and treatment of male urethral stricture. A clinical framework to guide providers in the diagnosis ...
STRICTURES of the human urethra are of three types: inflammatory, traumatic and congenital. The basic histology 1 common to all strictures is a proliferation of fibroblasts in the tunica propria. This ...
The global market for treating urethral strictures is segmented by type of posterior and anterior, treatment through urethral dilation, direct vision internal urethrotomy (DVIU), anastomotic and ...
A novel and relatively pain-less treatment method for male urethral stricture using patients own buccal mucosal cells has been reported as successful in four out of six patients. The study has been ...
Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients ...
Optilume is a urethral balloon coated with paclitaxel (3.5 microgram/mm 2). It is indicated for managing urethral stricture disease in 'adult males'. It is designed to be used as a drug-coated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results